How to handle off-label prescriptions of rupatadine, a second-generation antihistamine and PAF antagonist: a review
The off-label use of second-generation antihistamines, used outside of the formal indications authorized by regulatory authorities, in different age groups, doses or in special populations, is very common for many allergic, autoimmune and dermatological diseases. The off-label use of rupatadine (a s...
Main Authors: | Iñaki Izquierdo, Laia Casas, Susana Cabrera, Alberto Fernandez |
---|---|
Format: | Article |
Language: | English |
Published: |
BioExcel Publishing Ltd
2024-01-01
|
Series: | Drugs in Context |
Subjects: | |
Online Access: | https://www.drugsincontext.com/how-to-handle-off-label-prescriptions-of-rupatadine-a-second-generation-antihistamine-and-paf-antagonist-a-review/ |
Similar Items
-
Efficacy of increased dose of rupatadine up to 20 mg on itching in Japanese patients due to chronic spontaneous urticaria, dermatitis, or pruritus: A post hoc analysis of phase III clinical trial
by: Michihiro Hide, et al.
Published: (2019-10-01) -
Rupatadine oral solution for 2–5-year-old children with allergic rhinitis: a safety, open-label, prospective study
by: Santamaría E, et al.
Published: (2018-09-01) -
The benefit of H2 receptors antagonist Rupatadine in treatment for urticaria
by: A. A. Kubanov, et al.
Published: (2017-08-01) -
Higher efficacy of rupatadine 20 mg and 10 mg versus placebo in patients with perennial allergic rhinitis: a pooled responder analysis
by: Antonio Valero, et al.
Published: (2020-04-01) -
Knowledge and attitude of medical resident doctors toward antihistamines
by: Esha Chainani, et al.
Published: (2015-01-01)